Trial intelligence / Profile preview

LIMIT

PACTR202411891925662Phase 3Recruiting

Sponsor
Hamilton Health Sciences
Start
Sep 2019
Countries
1
01

Overview

Phase 3, open-label trial in prosthetic valve thrombosis (PVT) and None (2 arms), sponsored by Hamilton Health Sciences. Primary endpoints: Thrombosis/thromboembolism composite and Major bleeding. Started Sep 2019; status: recruiting.

02

Conditions

prosthetic valve thrombosis (PVT)

Beyond the preview

Go deeper on PACTR202411891925662.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202411891925662.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call